- World rank, 2022–2025
- #20,378 of 28,054 · #37,044 all time
- Rank in Russia
- #614 of 1,062
- Research works
- 244 ▲ 186% vs 2013–17
- Citations
- 1.1k 4.5 per fractional work
- Top-10% rate
- 2.0% record average 16.5%
- Open access
- 70% world 28%
What is Republican Oncological Clinical Dispensary known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,078 of 10,443 | 2.3% | 70 | #13212 | |
| Health SciencesDomain | #7,823 of 11,982 | 2.2% | 73 | #16305 |
Each strip is that field’s whole ranked pool, with the notch where Republican Oncological Clinical Dispensary sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Immunology and Microbiology 3.0×
- Dentistry 2.4×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Veterinary 1.2×
- Physics and Astronomy 1.0×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Psychology 0.6×
- Health Professions 0.5×
- Neuroscience 0.4×
- Economics, Econometrics and Finance 0.4×
- Decision Sciences 0.3×
- Social Sciences 0.2×
- Mathematics 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.0×
Who are the top researchers at Republican Oncological Clinical Dispensary?
Ranked on the composite score, Oleg Lipatov and А. В. Султанбаев lead among researchers whose main affiliation is Republican Oncological Clinical Dispensary.
- 1 Oleg Lipatov Russia · #143,205 worldwide 641 citations · 19 works
- 2 А. В. Султанбаев Russia · #169,755 worldwide 100 citations · 24 works
Which keywords describe research at Republican Oncological Clinical Dispensary?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Tumor Microenvironment, Treatment, Molecular Characterization, Survival Analysis and Breast Cancer.
- Lymph Node Dissection
- Cancer Incidence
- Nephron-Sparing Surgery
- Endoscopic Resection
- Genetic Testing
- Precision Medicine
- Therapy
- Hepatocellular Carcinoma
- Management
- Adjuvant Therapy
- PD-1 and PD-L1
- Metastasis
- Diagnosis
- Radiotherapy
- Prognostic Factors
- Cancer
- Breast Cancer
- Tumor Microenvironment
- Immunotherapy
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Treatment
- Molecular Characterization
- Survival Analysis
- Neoadjuvant Therapy
- Genetic Mutations
- Risk Factors
- Clinical Trials
- Immune Checkpoint Blockade
- Targeted Therapy
- Cancer Risk
- Ovarian Cancer
- Metastatic
- Clinical Guidelines
- Gastric Cancer
- Prevention
- Neoadjuvant Chemotherapy
- Renal Cell Carcinoma
- Metastatic Breast Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy10▲ 15×18 topics
- Clinical Practice Guidelines8▲ 14×10 topics
- Epidemiology7▲ 1.89×38 topics
- Immunotherapy7▲ 11×13 topics
- Treatment7▲ 5.8×18 topics
- Tumor Microenvironment6▲ 15×7 topics
- Molecular Characterization6▲ 34×5 topics
- Breast Cancer5▲ 23×7 topics
- Survival Analysis5▲ 20×6 topics
- Cancer5▲ 3.8×20 topics
- Neoadjuvant Therapy5▲ 20×5 topics
- Prognostic Factors5▲ 11×12 topics
- Genetic Mutations4▲ 11×10 topics
- Radiotherapy4▲ 12×10 topics
- Risk Factors4▲ 3.8×9 topics
- Diagnosis4▲ 4.3×15 topics
- Clinical Trials4▲ 5.9×7 topics
- Metastasis3▲ 10×8 topics
- Immune Checkpoint Blockade3▲ 30×1 topic
- PD-1 and PD-L13▲ 30×1 topic
- Targeted Therapy3▲ 14×4 topics
- Adjuvant Therapy3▲ 24×2 topics
- Cancer Risk3▲ 14×5 topics
- Management3▲ 3.9×12 topics
- Ovarian Cancer3▲ 34×2 topics
- Hepatocellular Carcinoma3▲ 14×3 topics
- Metastatic3▲ 48×2 topics
- Therapy3▲ 14×3 topics
- Clinical Guidelines3▲ 9.3×4 topics
- Precision Medicine3▲ 5.7×6 topics
- Gastric Cancer2▲ 22×3 topics
- Genetic Testing2▲ 22×2 topics
- Prevention2▲ 5.8×6 topics
- Endoscopic Resection2▲ 23×2 topics
- Neoadjuvant Chemotherapy2▲ 26×2 topics
- Nephron-Sparing Surgery2▲ 68×1 topic
- Renal Cell Carcinoma2▲ 68×1 topic
- Cancer Incidence2▲ 16×4 topics
- Metastatic Breast Cancer2▲ 38×2 topics
- Lymph Node Dissection2▲ 35×1 topic
Which research topics does Republican Oncological Clinical Dispensary publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Gastric Cancer Management and Outcomes and Advanced Radiotherapy Techniques.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 2 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 2 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 2 works
- 4 Advanced Radiotherapy Techniques Radiation 2 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 6 BRCA gene mutations in cancer Genetics 2 works
- 7 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 8 Cancer Genomics and Diagnostics Cancer Research 2 works
- 9 Liver Disease Diagnosis and Treatment Epidemiology 2 works
- 10 Healthcare Systems and Public Health Epidemiology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Republican Oncological Clinical Dispensary's research output changed?
Output in 2018–2022 was 186% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kazan’
- Kazan Federal University
- A.E. Arbuzov Institute of Organic and Physical Chemistry
- Kazan State Technological University
- Kazan State Medical University
- Kazan State Technical University named after A. N. Tupolev
- Kazan State Power Engineering University
- Innopolis University
- Kazan State University of Architecture and Engineering
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.